# AMI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ami-2

- Industry: Medical Devices & Equipment
- Headquarters: Kagoshima-shi, Japan
- Website: www.ami.inc
- Total disclosed funding: $12M
- Latest round: Series C (Mar 21, 2025)
- Investors on record: 16

## About

Based in Japan, AMI Inc. specializes in advanced medical technology, focusing on innovative solutions for remote diagnostics in cardiology and enhancing telehealth services with cloud-based systems.AMI Inc. was founded in 2015 and is headquartered in Kagoshima-shi, Japan. The company is engaged in developing advanced medical equipment. In May 2025, AMI Inc. raised an undisclosed amount in venture funding from a new investor Capital Medica Ventures.

AMI Inc. specializes in advanced medical technology, primarily through its flagship product, the "????" (Super Stethoscope) designed for remote medical diagnostics, particularly in cardiology. This stethoscope features diagnostic assistance functions, enabling healthcare professionals to perform remote auscultation and monitor heart sounds from a distance. The company’s offerings include the "AMI-SSS01 series," allowing heart sounds and electrocardiograms to be uploaded to the cloud for analysis, facilitating a remote medical support system branded as "??????®?" (Cloud Super Diagnosis). Primary customers include healthcare institutions, telemedicine providers, and medical professionals, particularly in cardiac care, with operations extending beyond Japan into international markets. AMI Inc. generates revenue primarily through the sale of its advanced medical devices and subscription services associated with its cloud-based analytical tools. The company engages in B2B transactions, partnering with healthcare facilities and telemedicine providers to integrate its systems into their existing frameworks. Their flagship products, including the Super Stethoscope and cloud services, have various pricing structures that reflect the integration of hardware and software solutions. Clients typically enter into agreements involving initial purchase costs for devices, followed by subscription fees for ongoing access to cloud analytics and support services. 

The company plans to use the May 2025 funding to improve the quality of medical care, strengthen the operations, especially in the Yamato region, and to expand nationwide and overseas.

## Funding rounds

- Series C, Mar 21, 2025 — Development Bank of Japan
- Series C, Dec 12, 2024 — Sagin Capital & Consulting, Miyazaki Taiyo Capital, Higin Capital, Nisshinbo Holdings Inc., Nangin Capital, DVx Inc., Hokuto Investments
- Series B, Jun 6, 2023, $6.5M — UntroD Capital, Higin Capital, Kips, PARAMOUNT BED CO., LTD., Nisshinbo Holdings Inc., Medical Data Vision Co., Ltd., KUMAMOTO TELECASTING CORPORATION
- Series A, May 14, 2020, $0.5M — Higin Capital, Beta Venture Capital
- Series A, Apr 10, 2020, $4.5M — Cyberdyne, Inc., UntroD Capital, CEJ Capital

## Investors

- Cyberdyne, Inc. — Series A
- UntroD Capital — Series A, Series B
- CEJ Capital (https://capitalatlas.ai/funds/cej-capital) — Series A
- Higin Capital (https://capitalatlas.ai/funds/higin-capital) — Series A, Series B, Series C
- Beta Venture Capital (https://capitalatlas.ai/funds/beta-venture-capital) — Series A
- Kips (https://capitalatlas.ai/funds/kips) — Series B
- PARAMOUNT BED CO., LTD. — Series B
- Nisshinbo Holdings Inc. — Series B, Series C
- Medical Data Vision Co., Ltd. — Series B
- KUMAMOTO TELECASTING CORPORATION — Series B
- Sagin Capital & Consulting (https://capitalatlas.ai/funds/sagin-capital-consulting) — Series C
- Miyazaki Taiyo Capital (https://capitalatlas.ai/funds/miyazaki-taiyo-capital) — Series C
- Nangin Capital (https://capitalatlas.ai/funds/nangin-capital) — Series C
- DVx Inc. — Series C
- Hokuto Investments — Series C
- Development Bank of Japan (https://capitalatlas.ai/funds/development-bank-of-japan) — Series C